NPCE

Kuhn Rebecca

Known title: Chief Financial OfficerCIK: 0001855659

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Keybanc Initiates Coverage on NeuroPace (NPCE) with Overweight Rating. Keybanc has started coverage of NeuroPace, giving it an overweight rating and a price target of $18. This follows the recent average analyst target of $20, which sits near the top of the 52‑week range of $9.22 to $19.60. The new rating adds to the company's positive outlook as it trades near its support level of $14.01 with an RSI of 41.9.

this person other insiders at NPCE

Transaction History

NPCE▼ Sell$18K
NPCE▼ Sell$5K
NPCE▼ Sell$55K
NPCE▼ Sell$3K
NPCE▲ Buy$0
NPCE▼ Sell$16K
NPCE▼ Sell$18K
NPCE▼ Sell$48K
NPCE▼ Sell$4K
NPCE▼ Sell$16K
NPCE▼ Sell$28K
NPCE▼ Sell$1K
NPCE▼ Sell$10K
NPCE▼ Sell$22K
NPCE▼ Sell$2K
NPCE▼ Sell$9K
NPCE▼ Sell$24K
NPCE▼ Sell$3K
NPCE▼ Sell$17K
NPCE▲ Buy$0
NPCE▼ Sell$172K
NPCE▼ Sell$3K
NPCE▼ Sell$9K
NPCE▼ Sell$1K
NPCE▼ Sell$9K
NPCE▼ Sell$739
NPCE▼ Sell$4K
NPCE▼ Sell$761
NPCE▼ Sell$16K
NPCE▲ Buy$0
NPCE▼ Sell$632
NPCE▲ Buy$18
NPCE▲ Buy$7
NPCE▲ Buy$13
NPCE▼ Sell$547
NPCE▼ Sell$993
NPCE▼ Sell$6K
NPCE▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.